{"name":"Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc.","slug":"ancora-bio-inc-d-b-a-embarkneuro-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ANC-501","genericName":"ANC-501","slug":"anc-501","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"ANC-501","genericName":"ANC-501","slug":"anc-501","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxOd0p6eTU0bHJFbDFqSV84R1BRcm01TF8yVlplZnE3VVE2dTJKOHR5ZFdOLWlKT2ZnbHlfdlBMNm9lVXVmMnBpejd2ajRxeEhhQk1CRHNPZE5GQ1VaYUJmanNuME5idFhJaW9BbnhmR0haTFRjWXZ3MlpKQ25EVnNHMVAyc0VWT2VubnN1SnpLRXliUGZLNFpfZGU1MEt5akluVTVZOTdpTHZXRjVobnVicVU3TGNIeTFoa0Z2azBYM0txclRDZVhDOFNkNTEtcE9ZREVFVW5xZ1JhV3lTVnZxRXNsQ3huZi15ZUEyS1dHcnIzZWlOX0hIZ0hCMGRLdWl6U01PcmZZcG1FLWhneWVGQzdtSmdlVk1PLUVrRlcxc1BRT2dmRFFHekN6TGlXYlZ3VzBRd3Vn?oc=5","date":"2025-01-22","type":"trial","source":"globenewswire.com","summary":"5-HT2 Agonist Clinical Trial Pipeline Appears Robust With - globenewswire.com","headline":"5-HT2 Agonist Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}